"The
Report OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma -
Opportunity Analysis and Forecast to 2024 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
The
head and neck cancer (HNC) market is one currently dominated by
generic chemotherapies, with little competition from branded
therapies. The market landscape is set to undergo substantial growth
between 2014 and 2024. The main drivers of growth will be an increase
in the diagnosed HNC population and the launch of multiple
premium-priced metastatic therapies, led by the class of
immuno-oncology products. Historically, cytotoxic chemotherapies have
comprised the bulk of the HNC market. Little competition between
targeted therapies currently exists in the HNC market, leaving an
area of considerable opportunity for interested new comers. Cisplatin
is the standard treatment for HNC, due to its greater efficacy over
other chemotherapy agents. However, as a cytotoxic agent, its use is
limited by its high toxicity and poor safety profile.
The
recent investment in HNC has seen a significant increase in research
activity. The launch of new agents into the market and continued
innovation in the developmental pipeline promises to produce a
dynamic market over the forecast period.
View Report at :
http://www.marketresearchreports.biz/analysis/716928
Highlights
Key Questions Answered
-
The HNC market is marked by the presence of a number of unmet needs
in current treatments. What are the main unmet needs in this market?
Will the drugs under
development
fulfil the unmet needs of the HNC market?
-
The late-stage HNC pipeline is varied and innovative. Will the
late-stage drugs make a significant impact on the HNC market? Which
of these drugs will have the highest peak sales at the highest CAGR,
and why?
-
The current HNC market is dominated by generic chemotherapy regimens
with little branded competition. How will the advent of new targeted
therapies change the treatment landscape for HNC? How will the drug
treatment rate change over the next ten years? What are the key
drivers and barriers to this change?
Key Findings
-
New drug launches will increase competition and drive expansion of
the HNC market. Over the forecast period, six pipeline drugs are
expected to file for approval in HNC and the launch of these premium
priced agents will drive significant increase in total drug sales in
the 7MM.
-
Immuno-oncology agents will be a major driver of treatment
innovation. Results from ongoing clinical trials are highly
anticipated by the medical community and combination therapies hold
promise of greater treatment efficacy.
-
The lack of predictive biomarkers in HNC will continue to pose an
issue in adopting personalized treatment, and the increasing costs of
new therapies will make this a more pressing issue.
-
KOLs interviewed for this report expressed a need for better
treatments in earlier lines of disease in order for treatments to be
effective. There needs to be an emphasis on the prevention of disease
recurrence, not just treating the recurrences after they occur.
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/716928
Scope
-
Overview of HNC, including epidemiology, etiology, pathophysiology,
symptoms, diagnosis, and treatment guidelines.
-
Annualized HNC therapeutics market revenue, annual cost of therapy
and treatment usage pattern data from 2014 and forecast for ten years
to 2024.
-
Key topics covered include strategic competitor assessment, market
characterization, unmet needs, clinical trial mapping and
implications for the HNC therapeutics market.
-
Pipeline analysis: comprehensive data split across different phases,
emerging novel trends under development, and detailed analysis of
late-stage pipeline drugs.
-
Analysis of the current and future market competition in the global
HNC therapeutics market. Insightful review of the key industry
drivers, restraints and challenges. Each trend is independently
researched to provide qualitative analysis of its implications.
Reasons to buy
The report will enable you
to -
-
Develop and design your in-licensing and out-licensing strategies
through a review of pipeline products and technologies, and by
identifying the companies with the most robust pipeline. Additionally
a list of acquisition targets included in the pipeline product
company list.
-
Develop business strategies by understanding the trends shaping and
driving the global HNC therapeutics market.
-
Drive revenues by understanding the key trends, innovative products
and technologies, market segments, and companies likely to impact the
global HNC therapeutics market in future.
-
Formulate effective sales and marketing strategies by understanding
the competitive landscape and by analysing the performance of various
competitors.
-
Track drug sales in the global HNC therapeutics market from
2014-2024.
-
Organize your sales and marketing efforts by identifying the market
categories and segments that present maximum opportunities for
consolidations, investments and strategic partnerships.
Table Of Content
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and
Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Biomarkers 28
3.1.3 Pathophysiology 30
3.1.4 Clinical Staging 32
3.2 Diagnosis 43
3.3 Symptoms 44
3.4 Prognosis 46
3.4.1 Quality of Life 46
4 Epidemiology 48
4.1 Risk Factors and
Comorbidities 48
4.2 Global and Historical
Trends 49
4.2.1 Incidence 49
4.2.2 Relative Survival - 7MM
53
4.3 Forecast Methodology 55
4.3.1 Sources Used 62
4.3.2 Sources Not Used 65
4.3.3 Forecast Assumptions and
Methods 65
4.4 Epidemiological Forecast
for HNC and Thyroid Cancer (2014-2024) 67
4.4.1 Diagnosed Incident Cases
of Lip, Oral Cavity, and Pharynx Cancer 67
4.4.2 Diagnosed Incident Cases
of Nose, Sinuses, and Related Cancers 68
4.4.3 Diagnosed Incident Cases
of Larynx Cancer 70
4.4.4 Diagnosed Incident Cases
of HNC 71
4.4.5 Diagnosed Incident Cases
of Thyroid Cancer 73
4.4.6 Age-Specific Diagnosed
Incident Cases of Lip, Oral Cavity, and P
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment